Floatz logo

231 assets in Endometrial Carcinoma

Therapeutic assets addressing Endometrial Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cldn6 (Claudin 6, Claudin-6)], Monoclonal Antibody (Ixotatug)
Endometrial Carcinoma
TORL Biotherapeutics, LLCP1C (37)
IPH5301
Endometrial Carcinoma
Institut Paoli-CalmettesP1C (37)
Lncb74
Endometrial Carcinoma
NextCure, Inc.P1C (37)
lyl797
Endometrial Carcinoma
Lyell Immunopharma, Inc.P1C (37)
MGC026
Endometrial Carcinoma
MacroGenicsP1C (37)
Moma-341
Endometrial Carcinoma
MOMA TherapeuticsP1C (37)
mov18 ige
Endometrial Carcinoma
Epsilogen LtdP1C (37)
Naptumomab Estafenatox
Endometrial Carcinoma
NeoTX Therapeutics Ltd.P1C (37)
nkt3447
Endometrial Carcinoma
NiKang Therapeutics, Inc.P1C (37)
nm32-2668
Endometrial Carcinoma
Numab Therapeutics AGP1C (37)
Nrm-823
Endometrial Carcinoma
Normunity AccelCo, Inc.P1C (37)
NT-112
Endometrial Carcinoma
AstraZenecaP1C (37)
Obinutuzumab
Endometrial Carcinoma
NeoTX Therapeutics Ltd.P1C (37)
pf-08046054
Endometrial Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (37)
Phn-010
Endometrial Carcinoma
Pheon TherapeuticsP1C (37)
Phst001
Endometrial Carcinoma
Pheast TherapeuticsP1C (37)
Pimitespib
Endometrial Carcinoma
Brown UniversityP1C (37)
rad301
Endometrial Carcinoma
Radiopharm Theranostics, LtdP1C (37)
Rgt-490
Endometrial Carcinoma
Regor Pharmaceuticals Inc.P1C (37)
Seclidemstat
Endometrial Carcinoma
HonorHealth Research InstituteP1C (37)
Slv-154
Endometrial Carcinoma
Solve TherapeuticsP1C (37)
Stro-004
Endometrial Carcinoma
Sutro Biopharma, Inc.P1C (37)
TH19P01-DOCETAXEL
Endometrial Carcinoma
TheratechnologiesP1C (37)
Vudalimab
Endometrial Carcinoma
Xencor, Inc.P2C (37)
Xmab541
Endometrial Carcinoma
Xencor, Inc.P1C (37)
Anti-Pd-L1 Monoclonal Antibody Ck-301
Endometrial Carcinoma
Checkpoint Therapeutics, Inc.P1C (36)
177lu-rad204
Endometrial Carcinoma
Radiopharm Theranostics, LtdEarly P1C (34)
Montelukast
Endometrial Carcinoma
University of South FloridaEarly P1C (34)
bi 3820768
Endometrial Carcinoma
Boehringer IngelheimP1NR ()
hb0025
Endometrial Carcinoma
Huabo Biopharm Co., Ltd.P1/2NR ()
Pazopanib
Endometrial Carcinoma
University Medical Center GroningenP4NR ()
Showing 201 to 231 of 231 assets
PreviousPage 5 of 5Next